27.07.2011 • News

Dow Chemical Sees Positive Q2; Sales Up 18%

Dow reported that its second-quarter net income available to the common shareholders rose to $982 million or $0.84 per share, from $566 million or $0.50 per share in the same quarter last year.

Excluding certain item, net income increased to $989 million or $0.85 per share, from $614 million or $0.54 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.81 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales for the quarter rose to $16.05 billion from $13.62 billion in the prior year quarter.

Ten analysts had consensus revenue estimate of $14.74 billion for the quarter. Sales increased 18%, driven by price gains of 17% compared with the same period last year.

 

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.